Related references
Note: Only part of the references are listed.Non-parametric recurrent events analysis with BART and an application to the hospital admissions of patients with diabetes
Rodney A. Sparapani et al.
BIOSTATISTICS (2020)
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy
Ruitao Lin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Causal Inference and Estimands in Clinical Trials
Ilya Lipkovich et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2020)
Bayesian optimal phaseIIclinical trial design with time-to-event endpoint
Heng Zhou et al.
PHARMACEUTICAL STATISTICS (2020)
A Bayesian adaptive phase II clinical trial design accounting for spatial variation
Beibei Guo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA (Multi-Ethnic Study of Atherosclerosis)
Rodney Sparapani et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Building Quantitative Structure-Activity Relationship Models Using Bayesian Additive Regression Trees
Dai Feng et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence
Baldur P. Magnusson et al.
STATISTICS IN MEDICINE (2019)
Estimands in clinical trials - broadening the perspective
Mouna Akach et al.
STATISTICS IN MEDICINE (2017)
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints
Heng Zhou et al.
STATISTICS IN MEDICINE (2017)
Estimands and Their Role in Clinical Trials
Mouna Akacha et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2017)
Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance
Weining Shen et al.
STATISTICS IN MEDICINE (2015)
A Bayesian phase I/II clinical trial design in the presence of informative dropouts
Beibei Guo et al.
STATISTICS AND ITS INTERFACE (2015)
STOCHASTIC COUNTERFACTUALS AND STOCHASTIC SUFFICIENT CAUSES
Tyler J. VanderWeele et al.
STATISTICA SINICA (2012)
THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE
Corwin M. Zigler et al.
ANNALS OF APPLIED STATISTICS (2011)
BART: BAYESIAN ADDITIVE REGRESSION TREES
Hugh A. Chipman et al.
ANNALS OF APPLIED STATISTICS (2010)
Randomized Clinical Trial of Behavioral Intervention and Nutrition Education to Improve Caloric Intake and Weight in Children With Cystic Fibrosis
Lori J. Stark et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2009)
Bayesian Design of Single-arm Phase II Clinical Trials with Continuous Monitoring
Valen E. Johnson et al.
CLINICAL TRIALS (2009)
Time out based discipline strategy for children's non-compliance with cystic fibrosis treatment
Catherine B. McClellan et al.
DISABILITY AND REHABILITATION (2009)
On the use of propensity scores in principal causal effect estimation
Booil Jo et al.
STATISTICS IN MEDICINE (2009)
A predictive probability design for phase II cancer clinical trials
J. Lack Lee et al.
CLINICAL TRIALS (2008)
Principal stratification with predictors of compliance for randomized trials with 2 active treatments
Jason Roy et al.
BIOSTATISTICS (2008)
Problems and solutions: Accounts by parents and children of adhering to chest physiotherapy for cystic fibrosis
Brian Williams et al.
DISABILITY AND REHABILITATION (2007)
Adaptive two-stage designs for single-arm phase IIA cancer clinical trials
Y Lin et al.
BIOMETRICS (2004)
Share Paper
